Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03712202 |
|---|---|
| Brief Title: | Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma |
| First Submitted : | August 6, 2018 |
| First Submitted that Met QC Criteria : | October 17, 2018 |
| First Posted : | October 19, 2018 |
| Last Update Submitted that Met QC Criteria : | April 30, 2024 |
| Last Update Posted : | May 2, 2024 |